WHAT IS NEW?
1. CD15+LOX-1+ PMN-MDSCs are a potential biomarker for NSCLC early diagnosis.
2. CD15+LOX-1+ PMN-MDSCs are associated with NSCLC prognosis and recurrence after surgery.